This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

No content found

Data pager
Data pager
12
 Item 1 to 99 of 116
of 2 
Show all 116
Data pager
Data pager
12
 Item 1 to 99 of 116
of 2 
Show all 116
Tuesday, February 03 | 4:00PM - 8:00PM
Arrival and Registration
Room: Keystone Lodge Lobby


Tuesday, February 03 | 6:00PM - 8:00PM
Welcome Mixer
Room: Keystone Lodge-Bighorn Bar
No registration fees are used to fund alcohol served at this function.

Wednesday, February 04 | 7:00AM - 8:00AM
Breakfast
Room: Shavano/Torreys


Wednesday, February 04 | 8:00AM - 9:00AM
Keynote Address
Room: Grays Peak

Speaker 1 of 2
* Jane L. Grogan, Arsenal Biosciences, USA
Welcome Remarks and Introduction

Wednesday, February 04 | 8:00AM - 9:00AM
Keynote Address
Room: Grays Peak

Speaker 2 of 2
Maria Grazia Roncarolo, Stanford University School of Medicine, USA
New Strategies for T Cell Regulation: Lessons from the Clinic

Wednesday, February 04 | 9:00AM - 11:30AM
Balancing Immune Homeostasis with Effector and Regulatory T
Cells

Room: Grays Peak

Speaker 1 of 6
* Jane L. Grogan, Arsenal Biosciences, USA

Wednesday, February 04 | 9:00AM - 11:30AM
Balancing Immune Homeostasis with Effector and Regulatory T
Cells

Room: Grays Peak

Speaker 2 of 6
Hilde Cheroutre, La Jolla Institute for Allergy and Immunology, USA
War and Peace at the Mucosal Front Line: A T Cell's Perspective

Wednesday, February 04 | 9:00AM - 11:30AM
Balancing Immune Homeostasis with Effector and Regulatory T
Cells

Room: Grays Peak

Speaker 3 of 6
Andrea Itano, Evelo Biosciences, USA
The Balancing between Treg and Th17 Function: Targeting Pathways for Use in the Clinic

Wednesday, February 04 | 9:00AM - 11:30AM
Balancing Immune Homeostasis with Effector and Regulatory T
Cells

Room: Grays Peak

Speaker 4 of 6
Jane H. Buckner, Benaroya Research Institute at Virginia Mason, USA
Human T Cell Checkpoints in Autoimmune Disease

Wednesday, February 04 | 9:00AM - 11:30AM
Balancing Immune Homeostasis with Effector and Regulatory T
Cells

Room: Grays Peak

Speaker 5 of 6
Connor J. Dwyer, University of Miami Miller School of Medicine, USA
Short Talk: Expression of a Mutant Transgenic IL-2RBeta Subunit in NOD Mice to further Define the IL-2-Dependent Risk in T1D

Wednesday, February 04 | 9:00AM - 11:30AM
Balancing Immune Homeostasis with Effector and Regulatory T
Cells

Room: Grays Peak

Speaker 6 of 6
Iona S. Schuster, University of Western Australia, Australia
Short Talk: TRAIL+ NK Cells Control CD4+ T Cell Responses during Chronic Viral Infection to Limit Autoimmunity

Wednesday, February 04 | 9:40AM - 10:00AM
Coffee Break
Room: Longs Peak Foyer


Wednesday, February 04 | 11:30AM - 1:00PM
Poster Setup
Room: Shavano/Torreys


Wednesday, February 04 | 11:30AM - 5:00PM
On Own for Lunch


Wednesday, February 04 | 1:00PM - 10:00PM
Poster Viewing
Room: Shavano/Torreys


Wednesday, February 04 | 2:30PM - 4:30PM
Workshop 1: Breakthrough Innovations in Understanding Pathog
enesis of Disease
Room: Grays Peak

Speaker 1 of 9
* Jennifer L. Gommerman, University of Toronto, Canada

Wednesday, February 04 | 2:30PM - 4:30PM
Workshop 1: Breakthrough Innovations in Understanding Pathog
enesis of Disease
Room: Grays Peak

Speaker 2 of 9
* Joan Goverman, University of Washington, USA

Wednesday, February 04 | 2:30PM - 4:30PM
Workshop 1: Breakthrough Innovations in Understanding Pathog
enesis of Disease
Room: Grays Peak

Speaker 3 of 9
Jessica L. Harakal, University of Virginia, USA
Loss of Regulatory T Cells Leads to Th2-Mediated Murine Autoimmune Gastritis

Wednesday, February 04 | 2:30PM - 4:30PM
Workshop 1: Breakthrough Innovations in Understanding Pathog
enesis of Disease
Room: Grays Peak

Speaker 4 of 9
Eddie A. James, Benaroya Research Institute, USA
Recognition of Modified Epitopes in Human Autoimmune Disease

Wednesday, February 04 | 2:30PM - 4:30PM
Workshop 1: Breakthrough Innovations in Understanding Pathog
enesis of Disease
Room: Grays Peak

Speaker 5 of 9
Hui Jin, Osaka University, Japan
Cellular Misfolded Proteins Rescued from Protein Degradation by MHC Class II Molecules Are Targets for Autoantibodies in Autoimmune Diseases

Wednesday, February 04 | 2:30PM - 4:30PM
Workshop 1: Breakthrough Innovations in Understanding Pathog
enesis of Disease
Room: Grays Peak

Speaker 6 of 9
Noriko Komatsu, University of Tokyo, Japan
Pathogenic Conversion of Foxp3+ T Cells into TH17 Cells in Autoimmune Arthritis

Wednesday, February 04 | 2:30PM - 4:30PM
Workshop 1: Breakthrough Innovations in Understanding Pathog
enesis of Disease
Room: Grays Peak

Speaker 7 of 9
Melissa D. LaJevic, Stanford University, USA
Chemerin/CMKLR1 Are Required for Maximal Skin Disease in Experimental Psoriasis

Wednesday, February 04 | 2:30PM - 4:30PM
Workshop 1: Breakthrough Innovations in Understanding Pathog
enesis of Disease
Room: Grays Peak

Speaker 8 of 9
Dana E. Orange, Rockefeller University, USA
Rheumatoid Arthritis Patient T Cells Can Recognize Neutrophil NETs Presented by Dendritic Cells

Wednesday, February 04 | 2:30PM - 4:30PM
Workshop 1: Breakthrough Innovations in Understanding Pathog
enesis of Disease
Room: Grays Peak

Speaker 9 of 9
John E. Connolly, Parker Institute for Cancer Immunotherapy, USA
Dominant Immune Tolerance Is Characterized by Rapid Metabolic Reprograming

Wednesday, February 04 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Wednesday, February 04 | 5:00PM - 7:15PM
Targeting Tolerogenic Pathways in Autoimmune Disease
Room: Grays Peak

Speaker 1 of 6
* Gerald T. Nepom, Benaroya Research Institute, USA

Wednesday, February 04 | 5:00PM - 7:15PM
Targeting Tolerogenic Pathways in Autoimmune Disease
Room: Grays Peak

Speaker 2 of 6
Joan Goverman, University of Washington, USA
How Different Effector T Cell Subsets Shape Inflammatory Pattern in Multiple Sclerosis

Wednesday, February 04 | 5:00PM - 7:15PM
Targeting Tolerogenic Pathways in Autoimmune Disease
Room: Grays Peak

Speaker 3 of 6
Jeffrey V. Ravetch, Rockefeller University, USA
Inhibitory Fc Receptors for IgG Maintain Peripheral Tolerance

Wednesday, February 04 | 5:00PM - 7:15PM
Targeting Tolerogenic Pathways in Autoimmune Disease
Room: Grays Peak

Speaker 4 of 6
David Klatzmann, Sorbonne University Medical School, France
Immunoregulation without Immunosuppression: The Promises of Low Dose IL2

Wednesday, February 04 | 5:00PM - 7:15PM
Targeting Tolerogenic Pathways in Autoimmune Disease
Room: Grays Peak

Speaker 5 of 6
Nathalie E. Blachère, Rockefeller University, USA
Short Talk: A New Mode of Tolerance Dictates Immune Responses to the Paraneoplastic Cerebellar Degeneration Antigen cdr2

Wednesday, February 04 | 5:00PM - 7:15PM
Targeting Tolerogenic Pathways in Autoimmune Disease
Room: Grays Peak

Speaker 6 of 6
Kenneth S. Tung, University of Virginia, USA
Short Talk: Sertoli Cell that Controls Testicular Barrier also Exports “Sequestered” Germ Cell Antigens to Maintain Regulatory T Cell-Dependent Systemic Tolerance

Wednesday, February 04 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Shavano/Torreys
No registration fees are used to fund alcohol served at this function.

Wednesday, February 04 | 7:30PM - 10:00PM
Poster Session 1
Room: Shavano/Torreys


Thursday, February 05 | 7:00AM - 8:00AM
Breakfast
Room: Shavano/Torreys


Thursday, February 05 | 8:00AM - 11:15AM
Cytokine Governance of Tolerance and Inflammation
Room: Grays Peak

Speaker 1 of 7
* Joanne L. Viney, Pandion Therapeutics, USA

Thursday, February 05 | 8:00AM - 11:15AM
Cytokine Governance of Tolerance and Inflammation
Room: Grays Peak

Speaker 2 of 7
Daniel J. Cua, Janssen Pharmaceutical Companies of Johnson & Johnson, USA
Role of IL-17 in Multiple Immune Checkpoints in Preclinical Models

Thursday, February 05 | 8:00AM - 11:15AM
Cytokine Governance of Tolerance and Inflammation
Room: Grays Peak

Speaker 3 of 7
Jennifer E. Towne, Janssen Research & Development LLC, USA
Differential Roles for IL-23 and IL-17 in Intestinal Immunoregulation: Lessons Learned from Mouse and Man

Thursday, February 05 | 8:00AM - 11:15AM
Cytokine Governance of Tolerance and Inflammation
Room: Grays Peak

Speaker 4 of 7
Jennifer L. Gommerman, University of Toronto, Canada
Role of the TNFSF in Regulating Immune Responses in Murine Models

Thursday, February 05 | 8:00AM - 11:15AM
Cytokine Governance of Tolerance and Inflammation
Room: Grays Peak

Speaker 5 of 7
Frank Oliver Nestle, Sanofi, USA
Immune Sentinels and Pathogenesis in Psoriasis in the Clinic

Thursday, February 05 | 8:00AM - 11:15AM
Cytokine Governance of Tolerance and Inflammation
Room: Grays Peak

Speaker 6 of 7
Carlos A. Arbelaez, Amgen, USA
Short Talk: IL-7/IL-7R Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis

Thursday, February 05 | 8:00AM - 11:15AM
Cytokine Governance of Tolerance and Inflammation
Room: Grays Peak

Speaker 7 of 7
Ester Planas-Rigol, Universitat de Barcelona, Spain
Short Talk: IL-35: A New Cytokine Involved in Vascular Inflammation

Thursday, February 05 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Thursday, February 05 | 11:15AM - 1:00PM
Poster Setup
Room: Shavano/Torreys


Thursday, February 05 | 11:15AM - 5:00PM
On Own for Lunch


Thursday, February 05 | 1:00PM - 10:00PM
Poster Viewing
Room: Shavano/Torreys


Thursday, February 05 | 2:30PM - 4:30PM
Workshop 2: Innovative Therapeutic Approaches for Treating D
isease
Room: Grays Peak

Speaker 1 of 10
* Maria Grazia Roncarolo, Stanford University School of Medicine, USA

Thursday, February 05 | 2:30PM - 4:30PM
Workshop 2: Innovative Therapeutic Approaches for Treating D
isease
Room: Grays Peak

Speaker 2 of 10
* David J. Rawlings, University of Washington, Seattle Children's Hospital Research Institute, USA

Thursday, February 05 | 2:30PM - 4:30PM
Workshop 2: Innovative Therapeutic Approaches for Treating D
isease
Room: Grays Peak

Speaker 3 of 10
Jaya Prakash Chalise, Linköping University, Sweden
Interferon alpha-Induced Tolerance against Antigen-Induced Arthritis Is Mediated by Indoleamine 2, 3 Dioxygenase

Thursday, February 05 | 2:30PM - 4:30PM
Workshop 2: Innovative Therapeutic Approaches for Treating D
isease
Room: Grays Peak

Speaker 4 of 10
Paul L. Bollyky, Stanford University, USA
Inhibition of Hyaluronan Synthesis Restores Immune Tolerance during Autoimmune Insulitis

Thursday, February 05 | 2:30PM - 4:30PM
Workshop 2: Innovative Therapeutic Approaches for Treating D
isease
Room: Grays Peak

Speaker 5 of 10
Wanjun Chen, NIDCR, National Institutes of Health, USA
Generating Antigen-Specific Treg Cells in vivo to Treat Autoimmunity

Thursday, February 05 | 2:30PM - 4:30PM
Workshop 2: Innovative Therapeutic Approaches for Treating D
isease
Room: Grays Peak

Speaker 6 of 10
Anne S. De Groot, EpiVax, Inc., USA
Tregitopes Induce Natural and iTreg Activation and Expansion: A Fully Synthetic Alternative to IgT for Autoimmune Disease?

Thursday, February 05 | 2:30PM - 4:30PM
Workshop 2: Innovative Therapeutic Approaches for Treating D
isease
Room: Grays Peak

Speaker 7 of 10
Chie Hotta-Iwamura, National Institutes of Health, USA
DCIR2+ cDC2 Dendritic Cells and zbtb32 Expression Restore CD4 T Cell Tolerance and Inhibit Diabetes

Thursday, February 05 | 2:30PM - 4:30PM
Workshop 2: Innovative Therapeutic Approaches for Treating D
isease
Room: Grays Peak

Speaker 8 of 10
Chantal Kuhn, USA
Differential Role of APCs in Induction of Th3 Cells and Oral Tolerance

Thursday, February 05 | 2:30PM - 4:30PM
Workshop 2: Innovative Therapeutic Approaches for Treating D
isease
Room: Grays Peak

Speaker 9 of 10
Alex F. Pellerin, Biogen Idec, USA
Anti-BDCA2 Monoclonal Antibody Inhibits Plasmacytoid Dendritic Cell Activation through Fc-Dependent and Independent Mechanisms

Thursday, February 05 | 2:30PM - 4:30PM
Workshop 2: Innovative Therapeutic Approaches for Treating D
isease
Room: Grays Peak

Speaker 10 of 10
Natasha C. Ward, University of Miami Miller School of Medicine, USA
Selective Enhancement of Tregs and Tolerance by a Novel IL-2-Based Biologic

Thursday, February 05 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Thursday, February 05 | 5:00PM - 7:15PM
Contribution of Antigen-Presenting Cells to Immune Homeostas
is

Room: Grays Peak

Speaker 1 of 6
* Jennifer L. Gommerman, University of Toronto, Canada

Thursday, February 05 | 5:00PM - 7:15PM
Contribution of Antigen-Presenting Cells to Immune Homeostas
is

Room: Grays Peak

Speaker 2 of 6
Boris Reizis, New York University Langone Medical Center, USA
The Role of Dendritic Cells in Experimental Models of Lupus

Thursday, February 05 | 5:00PM - 7:15PM
Contribution of Antigen-Presenting Cells to Immune Homeostas
is

Room: Grays Peak

Speaker 3 of 6
Clara Abraham, Yale University, USA
Unexpected Mechanisms for Disease-Associated Genes in Macrophage Regulation

Thursday, February 05 | 5:00PM - 7:15PM
Contribution of Antigen-Presenting Cells to Immune Homeostas
is

Room: Grays Peak

Speaker 4 of 6
Joanne L. Viney, Pandion Therapeutics, USA
Modulating Plasmacytoid Dendritic Cell Function for Treating Autoimmune Disease

Thursday, February 05 | 5:00PM - 7:15PM
Contribution of Antigen-Presenting Cells to Immune Homeostas
is

Room: Grays Peak

Speaker 5 of 6
Bryan J. Vander Lugt, Genentech, Inc., USA
Short Talk: Programming of Immunoregulatory Properties in Migratory Dendritic Cells

Thursday, February 05 | 5:00PM - 7:15PM
Contribution of Antigen-Presenting Cells to Immune Homeostas
is

Room: Grays Peak

Speaker 6 of 6
Nathalie Cools, University of Antwerp, Belgium
Short Talk: Dendritic Cells in Multiple Sclerosis: Key Players in the Immune Pathogenesis, Key Players for New Cellular Immunotherapies

Thursday, February 05 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Shavano/Torreys
No registration fees are used to fund alcohol served at this function.

Thursday, February 05 | 7:30PM - 10:00PM
Poster Session 2
Room: Shavano/Torreys


Friday, February 06 | 7:00AM - 8:00AM
Breakfast
Room: Shavano/Torreys


Friday, February 06 | 8:00AM - 11:15AM
Pathogenic and Regulatory B Cells in Autoimmune Disease
Room: Grays Peak

Speaker 1 of 7
* Carla V. Rothlin, Yale University, USA

Friday, February 06 | 8:00AM - 11:15AM
Pathogenic and Regulatory B Cells in Autoimmune Disease
Room: Grays Peak

Speaker 2 of 7
Ann Marshak-Rothstein, University of Massachusetts Medical School, USA
Role of B Cells, TLR and Type 1 IFNs in Murine Models of Lupus

Friday, February 06 | 8:00AM - 11:15AM
Pathogenic and Regulatory B Cells in Autoimmune Disease
Room: Grays Peak

Speaker 3 of 7
David J. Rawlings, University of Washington, Seattle Children's Hospital Research Institute, USA
Altered B Cell Signaling Orchestrates Loss of Tolerance and Systemic Autoimmunity

Friday, February 06 | 8:00AM - 11:15AM
Pathogenic and Regulatory B Cells in Autoimmune Disease
Room: Grays Peak

Speaker 4 of 7
Thomas F. Tedder, Duke University Medical Center, USA
Antigen-Specific B10 Cells Negatively Regulate Autoimmunity

Friday, February 06 | 8:00AM - 11:15AM
Pathogenic and Regulatory B Cells in Autoimmune Disease
Room: Grays Peak

Speaker 5 of 7
Eoin McKinney, Cambridge University, UK
Tired of Relapsing: T Cell Exhaustion and Outcome in Autoimmune Disease

Friday, February 06 | 8:00AM - 11:15AM
Pathogenic and Regulatory B Cells in Autoimmune Disease
Room: Grays Peak

Speaker 6 of 7
Arya Biragyn, NIA, National Institutes of Health, USA
Short Talk: Regulatory Function of Cancer-Expanded MDSCs Requires Education from Cancer Bregs

Friday, February 06 | 8:00AM - 11:15AM
Pathogenic and Regulatory B Cells in Autoimmune Disease
Room: Grays Peak

Speaker 7 of 7
Kira V. Rubtsova, Eli Lilly and Company, USA
Short Talk: T-Bet Expressing B Cells Are Required for the Development of Autoimmunity

Friday, February 06 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Friday, February 06 | 11:15AM - 1:00PM
Poster Setup
Room: Shavano/Torreys


Friday, February 06 | 11:15AM - 5:00PM
On Own for Lunch


Friday, February 06 | 1:00PM - 10:00PM
Poster Viewing
Room: Shavano/Torreys


Friday, February 06 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Friday, February 06 | 5:00PM - 7:00PM
New Perspectives on Tolerance and Autoimmunity
Room: Grays Peak

Speaker 1 of 5
* Arlene H. Sharpe, Harvard Medical School, USA

Friday, February 06 | 5:00PM - 7:00PM
New Perspectives on Tolerance and Autoimmunity
Room: Grays Peak

Speaker 2 of 5
Carla V. Rothlin, Yale University, USA
TAM Receptor Tyrosine Kinases Regulate the Magnitude of the Immune Response

Friday, February 06 | 5:00PM - 7:00PM
New Perspectives on Tolerance and Autoimmunity
Room: Grays Peak

Speaker 3 of 5
Gerald T. Nepom, Benaroya Research Institute, USA
In Pursuit of Immune Tolerance

Friday, February 06 | 5:00PM - 7:00PM
New Perspectives on Tolerance and Autoimmunity
Room: Grays Peak

Speaker 4 of 5
Robert H. Scannevin, Biogen Idec, USA
Immunomodulatory Pathways for Therapeutic Intervention in Multiple Sclerosis

Friday, February 06 | 5:00PM - 7:00PM
New Perspectives on Tolerance and Autoimmunity
Room: Grays Peak

Speaker 5 of 5
Roberto A. Maldonado, Selecta Biosciences, USA
Short Talk: Tolerogenic Synthetic Nanoparticles for the Treatment of Autoimmune Diseases

Friday, February 06 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Shavano/Torreys
No registration fees are used to fund alcohol served at this function.

Friday, February 06 | 7:30PM - 10:00PM
Poster Session 3
Room: Shavano/Torreys


Saturday, February 07 | 7:00AM - 8:00AM
Breakfast
Room: Shavano/Torreys


Saturday, February 07 | 8:00AM - 11:15AM
Positive and Negative Co-Stimulatory Pathways in Tolerance a
nd Autoimmunity

Room: Grays Peak

Speaker 1 of 8
* Deborah J. Fowell, University of Rochester, USA

Saturday, February 07 | 8:00AM - 11:15AM
Positive and Negative Co-Stimulatory Pathways in Tolerance a
nd Autoimmunity

Room: Grays Peak

Speaker 2 of 8
* Thomas R. Malek, University of Miami School of Medicine, USA

Saturday, February 07 | 8:00AM - 11:15AM
Positive and Negative Co-Stimulatory Pathways in Tolerance a
nd Autoimmunity

Room: Grays Peak

Speaker 3 of 8
Arlene H. Sharpe, Harvard Medical School, USA
Control of T Follicular Regulatory Cells and Humoral Immunity by Co-Inhibitory Pathways

Saturday, February 07 | 8:00AM - 11:15AM
Positive and Negative Co-Stimulatory Pathways in Tolerance a
nd Autoimmunity

Room: Grays Peak

Speaker 4 of 8
John Trowsdale, University of Cambridge, UK
Modulation of T Cells by Butyrophilin-Related Proteins

Saturday, February 07 | 8:00AM - 11:15AM
Positive and Negative Co-Stimulatory Pathways in Tolerance a
nd Autoimmunity

Room: Grays Peak

Speaker 5 of 8
Jane L. Grogan, Arsenal Biosciences, USA
Inhibitory Receptor TIGIT Limits Anti-Viral and Anti-Tumor T Cell Responses


Saturday, February 07 | 8:00AM - 11:15AM
Positive and Negative Co-Stimulatory Pathways in Tolerance a
nd Autoimmunity

Room: Grays Peak

Speaker 6 of 8
Dwight H. Kono, The Scripps Research Institute, USA
The Impact of Genes and Signaling Pathways in Systemic Lupus

Saturday, February 07 | 8:00AM - 11:15AM
Positive and Negative Co-Stimulatory Pathways in Tolerance a
nd Autoimmunity

Room: Grays Peak

Speaker 7 of 8
Alexandria Huynh, Harvard Medical School/Massachusetts General Hospital, USA
Short Talk: PTEN-Mediated Control of PI-3 Kinase in Regulatory T Cells Is Required for Homeostasis and Lineage Stability

Saturday, February 07 | 8:00AM - 11:15AM
Positive and Negative Co-Stimulatory Pathways in Tolerance a
nd Autoimmunity

Room: Grays Peak

Speaker 8 of 8
Georgina Espigol-Frigole, Hospital Clinic Barcelona, Spain
Short Talk: Identification of IL-23p19 as an Endothelial Pro-Inflammatory Peptide that Activates gp130-STAT3 Signaling

Saturday, February 07 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Saturday, February 07 | 11:15AM - 5:00PM
On Own for Lunch


Saturday, February 07 | 2:30PM - 4:30PM
Workshop 3: Novel in vitro and in vivo Models for Studying D
isease
Room: Grays Peak

Speaker 1 of 9
* Boris Reizis, New York University Langone Medical Center, USA

Saturday, February 07 | 2:30PM - 4:30PM
Workshop 3: Novel in vitro and in vivo Models for Studying D
isease
Room: Grays Peak

Speaker 2 of 9
* Hilde Cheroutre, La Jolla Institute for Allergy and Immunology, USA

Saturday, February 07 | 2:30PM - 4:30PM
Workshop 3: Novel in vitro and in vivo Models for Studying D
isease
Room: Grays Peak

Speaker 3 of 9
Marta E. Alarcón Riquelme, GENYO. Center for Genomics and Oncological Research, Spain
BANK1 Deficiency Ameliorates Lupus Phenotypes in B6.Sle1.yaa Mice

Saturday, February 07 | 2:30PM - 4:30PM
Workshop 3: Novel in vitro and in vivo Models for Studying D
isease
Room: Grays Peak

Speaker 4 of 9
Wei Cao, UT MD Anderson Cancer Center, USA
Neutrophils Regulate Humoral Autoimmunity by Restricting Interferon gamma Production from Natural Killer Cells

No content found

No content found

No content found